Yeshua Shainberg - Strainsforpains Pres Founder
EBYH Stock | USD 0.19 0.02 9.52% |
Insider
Yeshua Shainberg is Pres Founder of Strainsforpains
Age | 67 |
Phone | 646-481-4161 |
Web | https://strainsforpains.com |
Similar Executives
Showing other executives | INSIDER Age | ||
Jon Boumstein | National Research Corp | N/A | |
Pinal Patel | Veeva Systems Class | N/A | |
CMA MBA | OPTIMIZERx Corp | 56 | |
MD MPH | American Well Corp | 53 | |
Ido MD | American Well Corp | 60 | |
Peter Slavin | American Well Corp | 62 | |
Gregory MS | National Research Corp | N/A | |
CPA CPA | National Research Corp | 66 | |
Jim Rivas | Doximity | N/A | |
Jaap Mandema | Certara | N/A | |
Christine Mellon | Omnicell | 61 | |
Marshall Mohr | Veeva Systems Class | 65 | |
Amber Howe | American Well Corp | 48 | |
Derek Ross | American Well Corp | 48 | |
Susan Worthy | American Well Corp | 57 | |
Deval Patrick | American Well Corp | 63 | |
Nate Gross | Doximity | N/A | |
Nicolette Sherman | Certara | 54 | |
Andrew Schemick | Certara | 50 | |
Perry Gold | Doximity | N/A | |
Roxanne Turner | Omnicell | N/A |
Strainsforpains Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Strainsforpains a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 1.56 M | |||
Price To Earning | (0.87) X | |||
Net Income | (66.08 K) | |||
Cash And Equivalents | 2.29 K | |||
Total Debt | 1.81 M | |||
Book Value Per Share | (2.94) X | |||
Cash Flow From Operations | (66.08 K) | |||
Earnings Per Share | (0.23) X | |||
Beta | 1.23 | |||
Market Capitalization | 1.78 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Strainsforpains Pink Sheet
Strainsforpains financial ratios help investors to determine whether Strainsforpains Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Strainsforpains with respect to the benefits of owning Strainsforpains security.